Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial.
Catovsky D, Richards S, Matutes E, Oscier D, Dyer M, Bezares RF, Pettitt AR, Hamblin T, Milligan DW, Child JA, Hamilton MS, Dearden CE, Smith AG, Bosanquet AG, Davis Z, Brito-Babapulle V, Else M, Wade R, Hillmen P; UK National Cancer Research Institute (NCRI) Haematological Oncology Clinical Studies Group; NCRI Chronic Lymphocytic Leukaemia Working Group. Catovsky D, et al. Among authors: smith ag. Lancet. 2007 Jul 21;370(9583):230-239. doi: 10.1016/S0140-6736(07)61125-8. Lancet. 2007. PMID: 17658394 Clinical Trial.
The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia.
Dearden C, Wade R, Else M, Richards S, Milligan D, Hamblin T, Catovsky D; UK National Cancer Research Institute (NCRI); Haematological Oncology Clinical Studies Group; NCRI CLL Working Group. Dearden C, et al. Blood. 2008 Feb 15;111(4):1820-6. doi: 10.1182/blood-2007-07-101303. Epub 2007 Nov 30. Blood. 2008. PMID: 18055869 Free article. Clinical Trial.
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial.
Morgan GJ, Davies FE, Gregory WM, Cocks K, Bell SE, Szubert AJ, Navarro-Coy N, Drayson MT, Owen RG, Feyler S, Ashcroft AJ, Ross F, Byrne J, Roddie H, Rudin C, Cook G, Jackson GH, Child JA; National Cancer Research Institute Haematological Oncology Clinical Study Group. Morgan GJ, et al. Lancet. 2010 Dec 11;376(9757):1989-99. doi: 10.1016/S0140-6736(10)62051-X. Epub 2010 Dec 3. Lancet. 2010. PMID: 21131037 Free PMC article. Clinical Trial.
True outlook in acute myeloblastic leukaemia.
Copplestone JA, Smith AG, Oscier DG, Hamblin TJ. Copplestone JA, et al. Among authors: smith ag. Lancet. 1986 May 10;1(8489):1104. doi: 10.1016/s0140-6736(86)91376-0. Lancet. 1986. PMID: 2871376 No abstract available.
Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL.
Johnson S, Smith AG, Löffler H, Osby E, Juliusson G, Emmerich B, Wyld PJ, Hiddemann W. Johnson S, et al. Among authors: smith ag. Lancet. 1996 May 25;347(9013):1432-8. doi: 10.1016/s0140-6736(96)91681-5. Lancet. 1996. PMID: 8676625 Clinical Trial.
BEAM autografting in lymphoma--experience at one centre.
Smith AG, Long SG, Janmohammed RM, Macdonald DF, Leyland MJ, Milligan DW. Smith AG, et al. Leuk Lymphoma. 1992;7 Suppl:23-8. doi: 10.3109/10428199209061560. Leuk Lymphoma. 1992. PMID: 1493455 Clinical Trial.
1,103 results